IMMX NASDAQ
Immix Biopharma, Inc.
1W: -9.7%
1M: -29.8%
3M: -1.5%
YTD: +48.2%
1Y: +123.0%
3Y: +172.9%
$8.05
-0.01 (-0.12%)
Weekly Expected Move ±9.7%
$7
$7
$8
$9
$10
Credit Risk of going bust: lower than 74% of companies Debt: 0.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), Immix Biopharma, Inc. would be worth roughly what it owes.
Total debt $1.0M against a stock market value of $667.4M.
Distance to default 8.22 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $501K (short-term plus half of long-term), stock volatility 83.8%; Altman Z'' 26.88. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down more than 99.9%), Immix Biopharma, Inc. would be worth roughly what it owes.
Total debt $1.0M against a stock market value of $667.4M.
Distance to default 8.22 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $501K (short-term plus half of long-term), stock volatility 83.8%; Altman Z'' 26.88. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships3
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2023-01-18
Earliest Filing
2023-07-14
Latest Filing
partner: 2
investor: 1
Counterparties (Filed by IMMX)
3 relationshipsCompanies named in IMMX's SEC 8-K filings as business counterparties.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-30 | Other Events; Exhibits | View | |
| 2026-09-29 | Regulation FD; Other Events; Exhibits | View | |
| 2026-07-20 | Other Events | View | |
| 2026-05-29 | Shareholder Vote | View | |
| 2026-05-21 | Regulation FD; Other Events; Exhibits | View | |
| 2026-05-21 | Other Events; Exhibits | View | |
| 2026-03-30 | Regulation FD; Other Events; Exhibits | View | |
| 2026-03-25 | Material Agreement; Exhibits | Agreement | View |
| 2025-12-08 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-12-08 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-11-26 | Other Events; Financial Statements and Exhibits | View | |
| 2025-09-08 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Departure/Electio | Agreement | View |
| 2025-06-23 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-06-03 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2024-07-22 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View | |
| 2024-06-14 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2024-05-20 | Unregistered Sales of Equity Securities; Other Events; Financial Statements and Exhibits | View | |
| 2024-02-06 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2024-02-05 | Other Events | View | |
| 2023-08-22 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Departure/Electio | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR